Stockreport

Castle Biosciences Highlights DECIDE Study: DecisionDx-Melanoma Refines SLNB and Recurrence Risk [Yahoo! Finance]

Castle Biosciences, Inc. - Common stock  (CSTL) 
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm Check Earnings Report
PDF The prospective multicenter DECIDE study validated Castle's 31-gene DecisionDx-Melanoma test and its model outputs ( i31-SLNB and i31-ROR ), showing strong stratificati [Read more]